During the past decade, Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" #1 sponsor was "Abbott" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Hoosier Cancer Research Network" with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" #1 collaborator was "Bayer" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Thoracic Oncology Group Australasia (TOGA)" with 1 trials as a collaborator and "University of Sydney" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" are "Colonic Neoplasms" (2 trials), "Colorectal Neoplasms" (2 trials), "Rectal Neoplasms" (2 trials), "Breast Cancer" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" in a lesser frequency.

Most popular intervention types in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" are "Drug" (10 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (2 trials), "Bevacizumab" (2 trials), "Pemetrexed" (2 trials), "Vatalanib" (2 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr" are 7 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology-Evanston Nthwest Healthcare Kellogg Cancer Care Ctr, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".